L. Caldeira

发表

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

Evolving epidemiology of carbapenemase-producing Enterobacteriaceae in Portugal: 2012 retrospective cohort at a tertiary hospital in Lisbon.

D. Pires, L. Lito, A. Duarte, 2016, The Journal of hospital infection.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe

A. Mocroft, H. Stellbrink, J. Lundgren, 2021, HIV medicine.

Liver-related death among HIV/HCV coinfected indivi duals, implications for the era of directly acting ant ivirals

P. Vanhems, O. Kirk, R. Paredes, 2014 .

Receiving a positive HIV test result: the experience of patients in Europe

C. Dreezen, R. Colebunders, R. Andraghetti, 2001, HIV medicine.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

A. Mocroft, A. d’Arminio Monforte, A. Clarke, 2018, HIV medicine.

Utilization of healthcare services by people living with HIV/AIDS in Europe

C. Dreezen, Y. Coppieters, R. Colebunders, 2000, International journal of STD & AIDS.

Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients

N. Taveira, C. Afonso, P. Brogueira, 2021, Scientific Reports.

On the parameteres estimation of HIV dynamic models

Carla M. A. Pinto, João Nuno Tavares, Diana Rocha, 2018 .

Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment

C. Afonso, Márcia Boura, E. Valadas, 2014, Journal of the International AIDS Society.

Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study

A. Phillips, J. Lundgren, J. Baker, 2018, The Journal of infectious diseases.

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study

J. Nielsen, C. Leen, P. Vanhems, 2015, HIV medicine.

Characterization of a large cluster of HIV-1 A1 infections detected in Portugal and connected to several Western European countries

Pedro M M Araújo, A. Abecasis, N. Osório, 2019, Scientific Reports.